BENZENE DERIVATIVES

Novel benzene derivatives of the formula (I) shown below, pharmacological salts thereof, pharmacological solvates of the above-mentioned benzene derivatives and salts, pharmaceutical compositions including, as active ingredients, the above-mentioned compounds, and especially, prophylactic or therape...

Full description

Saved in:
Bibliographic Details
Main Authors HASEGAWA, MASAICHI, TAKAHASHI, KATSUSHI, TAKEYASU, TAKUMI, TSUCHIYA, NAOKI, HASE, NAOKI, KAMIMURA, TAKASHI
Format Patent
LanguageEnglish
French
Published 05.06.1997
Edition6
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Novel benzene derivatives of the formula (I) shown below, pharmacological salts thereof, pharmacological solvates of the above-mentioned benzene derivatives and salts, pharmaceutical compositions including, as active ingredients, the above-mentioned compounds, and especially, prophylactic or therapeutic medicines for allergic diseases. (see formula I) wherein R1 - H, C1 - C12 cyclic or straight or branched chain alkyl group (which may be substituted by one or more C6 - C10 aryloxy groups), C7 - C12 aralkyl group (of which the aryl group may be substituted one or more of halogen, methyl and methoxy, or C3 - C10 alkenyl which may be substituted by one or more phenyl groups; A = O, S or CH2 group, B = CO or CZ2CO group (Z = H or F), R2 - H or C1 - C4 alkyl group, X = halogen or methyl group, and Y = H; NO2 or CN group. Novel benzene derivatives represented by general formula (I) which are characterized by having a potent effect of inhibiting IgE antibody production and usable as a preventive or remedy for allergic diseases, pharmaceutically acceptable salts of the same or solvates thereof; and medicinal compositions containing the same as the active ingredient, in particular, preventives or remedies for allergic diseases. In said formula, R1 represents H, cyclic, linear or branched C1-12 alkyl optionally substituted by one or more C6-10 aryloxy groups, C7-12 aralkyl wherein the aryl group optionally has one or more substituents such as halogeno, methyl or methoxy, or C3-10 alkenyl optionally substituted by one or more phenyl groups; A represents O, S or CH2; B represents CO or CZ2CO wherein Z is H or F; R2 represents H or C1-4 alkyl; X represents halogeno or methyl; and Y represents H, NO2 or CN.
Bibliography:Application Number: CA19962210579